Your browser doesn't support javascript.
loading
Generic MS-based method for the bioanalysis of therapeutic monoclonal antibodies in nonclinical studies.
Hashii, Noritaka; Tousaka, Yoshiko; Arai, Koji; Goda, Ryoya; Inoue, Noriko; Murata, Kazuyuki; Okuzono, Takeshi; Sasahara, Satomi; Shigeyama, Takuma; Tachiki, Hidehisa; Yamane, Shinichi; Saito, Yoshiro; Ishii-Watabe, Akiko.
Afiliación
  • Hashii N; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
  • Tousaka Y; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
  • Arai K; Bioanalysis Department, Advanced Technology Center, Medical Solution Segment, LSI Medience Corp., 30-1, Shimura 3-chome, Itabashi-ku, Tokyo 174-8555, Japan.
  • Goda R; Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd, 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan.
  • Inoue N; Scientific Research and Business Development Department, Towa Pharmaceutical Co., Ltd, Kyoto Research Park KISTIC #202, 134 Chudoji Minami-machi, Shimogyo-ku, Kyoto 600-8818, Japan.
  • Murata K; Current address: Scientific Research and Business Development Department, Towa Pharmaceutical Co., Ltd, National Cerebral & Cardiovascular Center #30602, 6-1, Kishibe Shinmachi, Suita, Osaka 564-8565, Japan.
  • Okuzono T; Osaka Laboratory, Technical Solution Headquarters Sumika Chemical Analysis Service, Ltd, 1-135, Kasugade-naka 3-chome, Konohana-ku, Osaka 554-0022, Japan.
  • Sasahara S; Drug Development Solutions Center, Sekisui Medical Co., Ltd, 2117 Muramatsu, Tokai-mura, Naka-gun, Ibaraki 319-1182, Japan.
  • Shigeyama T; Scientific Research and Business Development Department, Towa Pharmaceutical Co., Ltd, Kyoto Research Park KISTIC #202, 134 Chudoji Minami-machi, Shimogyo-ku, Kyoto 600-8818, Japan.
  • Tachiki H; Osaka Laboratory, Technical Solution Headquarters Sumika Chemical Analysis Service, Ltd, 1-135, Kasugade-naka 3-chome, Konohana-ku, Osaka 554-0022, Japan.
  • Yamane S; Scientific Research and Business Development Department, Towa Pharmaceutical Co., Ltd, Kyoto Research Park KISTIC #202, 134 Chudoji Minami-machi, Shimogyo-ku, Kyoto 600-8818, Japan.
  • Saito Y; Drug Development Solutions Center, Sekisui Medical Co., Ltd, 2117 Muramatsu, Tokai-mura, Naka-gun, Ibaraki 319-1182, Japan.
  • Ishii-Watabe A; Division of Medical Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
Bioanalysis ; 12(4): 231-243, 2020 Feb.
Article en En | MEDLINE | ID: mdl-32090608
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espectrometría de Masas en Tándem / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Bioanalysis Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espectrometría de Masas en Tándem / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Bioanalysis Año: 2020 Tipo del documento: Article País de afiliación: Japón